• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口服生物制剂的药物-器械组合给药。

Oral delivery of biologics using drug-device combinations.

机构信息

Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Chemical Engineering and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

Department of Chemical Engineering and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

出版信息

Curr Opin Pharmacol. 2017 Oct;36:8-13. doi: 10.1016/j.coph.2017.07.003. Epub 2017 Aug 2.

DOI:10.1016/j.coph.2017.07.003
PMID:28779684
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5732838/
Abstract

Orally administered devices could enable the systemic uptake of biologic therapeutics by engineering around the physiological barriers present in the gastrointestinal (GI) tract. Such devices aim to shield cargo from degradative enzymes and increase the diffusion rate of medication through the GI mucosa. In order to achieve clinical relevance, these designs must significantly increase systemic drug bioavailability, deliver a clinically relevant dose and remain safe when taken frequently. Such an achievement stands to reduce our dependence on needle injections, potentially increasing patient adherence and reducing needle-associated complications. Here we discuss the physical and chemical constraints imposed by the GI organs and use these to develop a set of boundary conditions on oral device designs for the delivery of macromolecules. We critically examine how device size affects the rate of intestinal obstruction and hinders the loading capacity of poorly soluble protein drugs. We then discuss how current orally administered devices could solve the problem of tissue permeation and conclude that these physical methods stand to provide an efficacious set of alternatives to the classic hypodermic needle.

摘要

口服给药装置可以通过绕过胃肠道 (GI) 中存在的生理屏障来实现生物治疗药物的全身吸收。这些装置旨在保护药物不受降解酶的影响,并增加药物通过 GI 黏膜的扩散速度。为了实现临床相关性,这些设计必须显著提高系统药物生物利用度,输送临床相关剂量,并在频繁使用时保持安全。这一成就有望减少我们对针注射的依赖,可能会提高患者的依从性并减少与针相关的并发症。在这里,我们讨论了 GI 器官施加的物理和化学限制,并利用这些限制为大分子的口服给药装置设计制定了一组边界条件。我们批判性地研究了装置尺寸如何影响肠梗阻的速度并阻碍了难溶性蛋白质药物的载药量。然后,我们讨论了目前的口服给药装置如何解决组织渗透问题,并得出结论,这些物理方法为经典的皮下注射针提供了一套有效的替代方法。

相似文献

1
Oral delivery of biologics using drug-device combinations.口服生物制剂的药物-器械组合给药。
Curr Opin Pharmacol. 2017 Oct;36:8-13. doi: 10.1016/j.coph.2017.07.003. Epub 2017 Aug 2.
2
Recent advances in oral delivery of biologics: nanomedicine and physical modes of delivery.生物制品经口腔给药的最新进展:纳米医学和物理给药模式。
Expert Opin Drug Deliv. 2018 Aug;15(8):759-770. doi: 10.1080/17425247.2018.1504017. Epub 2018 Jul 27.
3
Challenges and Future Prospects for the Delivery of Biologics: Oral Mucosal, Pulmonary, and Transdermal Routes.生物制剂递送的挑战与未来前景:口腔黏膜、肺部和透皮途径
AAPS J. 2017 May;19(3):652-668. doi: 10.1208/s12248-017-0054-z. Epub 2017 Feb 13.
4
Dosing considerations for inhaled biologics.吸入性生物制剂的剂量考虑因素。
Int J Pharm. 2018 Oct 5;549(1-2):58-66. doi: 10.1016/j.ijpharm.2018.07.054. Epub 2018 Jul 24.
5
Microfabricated devices for oral drug delivery.微纳加工的口服给药装置。
Lab Chip. 2018 Aug 7;18(16):2348-2358. doi: 10.1039/c8lc00408k.
6
Orally ingestible medical devices for gut engineering.用于肠道工程的口服可食用医疗设备。
Adv Drug Deliv Rev. 2020;165-166:142-154. doi: 10.1016/j.addr.2020.05.004. Epub 2020 May 13.
7
Overview and Future Potential of Buccal Mucoadhesive Films as Drug Delivery Systems for Biologics.颊黏膜黏附膜作为生物制品药物递送系统的概述及未来潜力
AAPS PharmSciTech. 2017 Jan 1;18(1):3-14. doi: 10.1208/s12249-016-0525-z. Epub 2016 Apr 15.
8
Oral Delivery of Biologics for Precision Medicine.精准医学的生物制剂口服递药
Adv Mater. 2020 Apr;32(13):e1901935. doi: 10.1002/adma.201901935. Epub 2019 Jun 20.
9
Fabrication of Sealed Nanostraw Microdevices for Oral Drug Delivery.密封纳米吸管微器件的制作用于口服给药。
ACS Nano. 2016 Jun 28;10(6):5873-81. doi: 10.1021/acsnano.6b00809. Epub 2016 Jun 13.
10
Design control considerations for biologic-device combination products.生物器械组合产品的设计控制考虑因素。
Adv Drug Deliv Rev. 2017 Mar;112:101-105. doi: 10.1016/j.addr.2017.01.003. Epub 2017 Jan 11.

引用本文的文献

1
Mucoadhesive-to-Mucopenetrating Nanoparticles for Mucosal Drug Delivery: A Mini Review.用于黏膜给药的黏膜黏附-黏膜穿透纳米颗粒:综述
Int J Nanomedicine. 2025 Feb 20;20:2241-2252. doi: 10.2147/IJN.S505427. eCollection 2025.
2
Gastrointestinal Permeation Enhancers Beyond Sodium Caprate and SNAC - What is Coming Next?超越癸酸钠和 SNAC 的胃肠道渗透增强剂 - 接下来会有什么?
Adv Sci (Weinh). 2024 Sep;11(33):e2400843. doi: 10.1002/advs.202400843. Epub 2024 Jun 17.
3
Oral administration microrobots for drug delivery.用于药物递送的口服微型机器人。

本文引用的文献

1
Intestinal mucoadhesive devices for oral delivery of insulin.用于口服胰岛素递送的肠道粘膜粘附装置。
Bioeng Transl Med. 2016 Aug 19;1(3):338-346. doi: 10.1002/btm2.10015. eCollection 2016 Sep.
2
Scalable fabrication of size-controlled chitosan nanoparticles for oral delivery of insulin.可扩展制备尺寸可控的壳聚糖纳米粒用于胰岛素口服递送。
Biomaterials. 2017 Jun;130:28-41. doi: 10.1016/j.biomaterials.2017.03.028. Epub 2017 Mar 22.
3
An oral microjet vaccination system elicits antibody production in rabbits.一种口腔微喷疫苗接种系统可在兔子体内引发抗体产生。
Bioact Mater. 2024 May 21;39:163-190. doi: 10.1016/j.bioactmat.2024.05.005. eCollection 2024 Sep.
4
Recent advances in oral insulin delivery technologies.口服胰岛素递药技术的最新进展。
J Control Release. 2024 Feb;366:221-230. doi: 10.1016/j.jconrel.2023.12.045. Epub 2024 Jan 4.
5
Untethered shape-changing devices in the gastrointestinal tract.消化道内的非束缚型形状变化装置。
Expert Opin Drug Deliv. 2023 Jul-Dec;20(12):1801-1822. doi: 10.1080/17425247.2023.2291450. Epub 2023 Dec 29.
6
Oral delivery of RNAi for cancer therapy.癌症治疗的 RNAi 口服递送。
Cancer Metastasis Rev. 2023 Sep;42(3):699-724. doi: 10.1007/s10555-023-10099-x. Epub 2023 Mar 27.
7
A self-powered ingestible wireless biosensing system for real-time in situ monitoring of gastrointestinal tract metabolites.一种自供电的可摄入式无线生物传感系统,用于实时原位监测胃肠道代谢物。
Nat Commun. 2022 Dec 1;13(1):7405. doi: 10.1038/s41467-022-35074-y.
8
Autonomous Untethered Microinjectors for Gastrointestinal Delivery of Insulin.自主非束缚式微注射器,用于胃肠道内胰岛素投递。
ACS Nano. 2022 Oct 25;16(10):16211-16220. doi: 10.1021/acsnano.2c05098. Epub 2022 Oct 6.
9
Mucus interaction to improve gastrointestinal retention and pharmacokinetics of orally administered nano-drug delivery systems.改善口服纳米给药系统在胃肠道中的滞留和药代动力学的黏液相互作用。
J Nanobiotechnology. 2022 Aug 6;20(1):362. doi: 10.1186/s12951-022-01539-x.
10
Foundations of gastrointestinal-based drug delivery and future developments.胃肠道给药的基础与未来发展。
Nat Rev Gastroenterol Hepatol. 2022 Apr;19(4):219-238. doi: 10.1038/s41575-021-00539-w. Epub 2021 Nov 16.
Sci Transl Med. 2017 Mar 8;9(380). doi: 10.1126/scitranslmed.aaf6413.
4
Ultrasound-Mediated Delivery of RNA to Colonic Mucosa of Live Mice.超声介导的RNA向活体小鼠结肠黏膜的递送
Gastroenterology. 2017 Apr;152(5):1151-1160. doi: 10.1053/j.gastro.2017.01.002. Epub 2017 Jan 11.
5
Complexation hydrogels as potential carriers in oral vaccine delivery systems.复合水凝胶作为口服疫苗递送系统中的潜在载体。
Eur J Pharm Biopharm. 2017 Mar;112:138-142. doi: 10.1016/j.ejpb.2016.11.029. Epub 2016 Nov 27.
6
In vitro and ex vivo strategies for intracellular delivery.体外和离体策略用于细胞内递药。
Nature. 2016 Oct 13;538(7624):183-192. doi: 10.1038/nature19764.
7
Fabrication of Sealed Nanostraw Microdevices for Oral Drug Delivery.密封纳米吸管微器件的制作用于口服给药。
ACS Nano. 2016 Jun 28;10(6):5873-81. doi: 10.1021/acsnano.6b00809. Epub 2016 Jun 13.
8
Enhancement of oral insulin bioavailability: in vitro and in vivo assessment of nanoporous stimuli-responsive hydrogel microparticles.口服胰岛素生物利用度的提高:纳米多孔刺激响应水凝胶微粒的体外和体内评估
Expert Opin Drug Deliv. 2016;13(5):621-32. doi: 10.1517/17425247.2016.1160889. Epub 2016 Mar 24.
9
Current status of selected oral peptide technologies in advanced preclinical development and in clinical trials.选定的口服肽技术在先进临床前开发和临床试验中的现状。
Adv Drug Deliv Rev. 2016 Nov 15;106(Pt B):223-241. doi: 10.1016/j.addr.2016.02.004. Epub 2016 Feb 24.
10
Needle free injection technology: A complete insight.无针注射技术:全面解析
Int J Pharm Investig. 2015 Oct-Dec;5(4):192-9. doi: 10.4103/2230-973X.167662.